Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

BACKGROUND We have developed a method to screen for pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) patients, based on a formula to predict mean pulmonary artery pressure (MPAP) from standard lung function measurements. The objective of this study was to validate this method in a separate group of IPF patients. METHODS Cross-sectional study of 60 IPF patients from two institutions. The accuracy of the MPAP estimation was assessed by examining the correlation between the predicted and measured MPAPs and the magnitude of the estimation error. The discriminatory ability of the method for PH was assessed using the area under the receiver operating characteristic curve (AUC). RESULTS There was strong correlation in the expected direction between the predicted and measured MPAPs (r = 0.72; p < 0.0001). The estimated MPAP was within 5 mm Hg of the measured MPAP 72% of the time. The AUC for predicting PH was 0.85, and did not differ by institution. A formula-predicted MPAP > 21 mm Hg was associated with a sensitivity, specificity, positive predictive value, and negative predictive value of 95%, 58%, 51%, and 96%, respectively, for PH defined as MPAP from right-heart catheterization > 25 mm Hg. CONCLUSIONS A prediction formula for MPAP using standard lung function measurements can be used to screen for PH in IPF patients.

[1]  J. Goldin,et al.  HIGH-RESOLUTION CHEST COMPUTED TOMOGRAPHY FINDINGS DO NOT PREDICT THE PRESENCE OF PULMONARY HYPERTENSION IN ADVANCED IDIOPATHIC PULMONARY FIBROSIS , 2007 .

[2]  A. Karlamangla,et al.  Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. , 2007, Respiratory medicine.

[3]  A. Borczuk,et al.  Pulmonary hypertension in idiopathic pulmonary fibrosis. , 2007, Chest.

[4]  J. Goldin,et al.  High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. , 2007, Chest.

[5]  S. Nathan,et al.  Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. , 2007, American journal of respiratory and critical care medicine.

[6]  M. Mishima,et al.  Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. , 2007, Chest.

[7]  S. Nathan,et al.  Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. , 2007, Chest.

[8]  S. Nathan,et al.  Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. , 2006, Chest.

[9]  P. Pellikka,et al.  The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. , 2005, Chest.

[10]  P. Pellikka,et al.  Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. , 2004, Chest.

[11]  M. Vogeser,et al.  Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.

[12]  D E Grobbee,et al.  External validation is necessary in prediction research: a clinical example. , 2003, Journal of clinical epidemiology.

[13]  M. Sutton,et al.  Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. , 2003, American journal of respiratory and critical care medicine.

[14]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[15]  K. Covinsky,et al.  Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.

[16]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[17]  A. Verbeek,et al.  External validation of prognostic models for ongoing pregnancy after in-vitro fertilization. , 1998, Human reproduction.

[18]  A. Verbeek,et al.  Prognostic models for the probability of achieving an ongoing pregnancy after in-vitro fertilization and the importance of testing their predictive value. , 1996, Human reproduction.

[19]  L. Neas,et al.  The determinants of pulmonary diffusing capacity in a national sample of U.S. adults. , 1996, American journal of respiratory and critical care medicine.

[20]  H. Nijmegen.  Prognostic models for the probability of achieving an ongoing pregnancy after in-vitro fertilization and the importance of testing their predictive value. , 1996, Human reproduction.

[21]  B. Dawson-Saunders,et al.  Basic and Clinical Biostatistics , 1993 .

[22]  E H Bergofsky,et al.  Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.

[23]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[24]  H. Z. Bencowitz.  Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. , 1983, The American review of respiratory disease.

[25]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[26]  H. Anderson,et al.  Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. , 1983, The American review of respiratory disease.

[27]  E. Weitzenblum,et al.  Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. , 1983, Respiration; international review of thoracic diseases.

[28]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[29]  M Terrin,et al.  Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.

[30]  A H Morris,et al.  Standardized single breath normal values for carbon monoxide diffusing capacity. , 2015, The American review of respiratory disease.